Use this Valacyclovir pediatric dose calculator to match the prescribed child dose to the exact liquid or capsule strength and confirm the timing plan before the first dose.
dose calculator basics
Use this Valacyclovir calculator as the fast parent page for weight-based dose checks, mL conversion, common strengths, and the practical safety steps that generic calculator sites often skip.
mL per dose = (child weight in kg x prescribed mg/kg/day / doses per day) / medication concentration in mg per mL.
For a 20 kg child using 60 mg/kg/day divided 3 times daily with 50 mg/1 mL, calculate the daily mg target, divide by the schedule, then convert that mg amount into mL for the selected product.
Practical dosing guide
Use this page to match the child's weight, the strength in hand, and the timing of illness before giving Valacyclovir.
Valacyclovir is the prodrug of acyclovir, offering higher exposure with fewer daily doses for HSV suppression and targeted varicella therapy in older children.
Valacyclovir is FDA approved for chickenpox in children 2 to under 18 years and for cold sores in patients ≥12 years; pediatric use for genital HSV, zoster, and suppression is not established (off-label).
Bioavailability is ~55% (versus 10–20% for acyclovir), allowing twice- or thrice-daily dosing rather than four or five daily doses.
Valacyclovir converts rapidly to acyclovir, offering improved bioavailability and simplified dosing for HSV and varicella-zoster therapy in older children.
Recurrent HSV labialis (cold sores): Best results occur when taken at the earliest tingling or burning.
Chronic HSV suppression: Counsel on condom use and disclosure even with suppression.
Varicella-zoster treatment: Consider IV acyclovir for severe or immunocompromised cases.
HSV-associated erythema multiforme prophylaxis: Coordinate dermatology follow-up for taper plans.
Post-exposure prophylaxis for high-risk varicella contacts: Consult infectious disease for immunocompromised hosts.
Cytomegalovirus prophylaxis in renal transplant recipients: Reserve for valganciclovir intolerance.
Valacyclovir adverse effects are usually mild, but safety depends on early recognition of renal or CNS toxicity signals in high-risk patients.
Valacyclovir is an oral prodrug rapidly converted to acyclovir, which is selectively activated in herpesvirus-infected cells and then inhibits viral DNA polymerase.
For episodic therapy, give the first dose at the earliest tingling, burning, or itching sensation. Waiting for a blister to appear reduces the benefit. Keep a dose accessible at home, school, or practice so teens can take it immediately.
Take it as soon as you remember unless the next scheduled dose is within 6 hours. For frequent missed doses, set phone alarms or use a pillbox. If two or more doses are missed in a week, contact the clinician to discuss restarting strategy and assess breakthrough lesions.
Yes, valacyclovir tablets can be split or crushed and mixed with soft food for children who cannot swallow pills. For weight-based chickenpox doses, the pharmacy can make a 25 mg/mL or 50 mg/mL suspension for more precise dosing; check which strength is on the bottle.
Short courses in healthy adolescents typically do not require labs. If your child has kidney disease, is on high-dose therapy, or is immunocompromised, clinicians may order baseline and follow-up renal tests.
Valacyclovir does not affect hormonal contraception or stimulants. Always provide a full medication list so clinicians can check for kidney-stressing drugs, pain relievers, or supplements that might interact.
Yes, but cover active lesions and avoid skin-to-skin sports (wrestling, rugby) until lesions crust to prevent transmission. Encourage teammates not to share water bottles or towels.
Tell your clinician about upcoming varicella or zoster vaccines. Valacyclovir should be paused 24 hours before and restarted 14 days after live vaccines when medically safe to ensure the vaccine works well.
Daily suppression reduces outbreaks and lowers the amount of virus shed, but it does not eliminate transmission risk. Continue using condoms or barriers and avoid sexual contact during active lesions.
dailymed-valacyclovir-2024
cdc-hsv-2024
mfc-valacyclovir-2024
cdc-varicella-2024
idsa-zoster-2016
statpearls-erythema-2024